Kidney Cancer

Sumanta K. Pal, MD, FASCO, expressed a mix of emotions.

Clinicians treating patients with tumor-infiltrating lymphocytes should closely monitor toxicities associated with interleukin-2 and halt administration of the drug if necessary, according to the first guidelines regarding the therapy.

Individuals with elevated and worsening metabolic syndrome had an increased risk for developing an array of cancer types compared with those who did not, according to results published in Cancer.

Adjuvant therapy with pembrolizumab following nephrectomy conferred significant improvement in OS compared with placebo among adults with renal cell carcinoma who had a high risk for disease recurrence, study results showed.

Subcutaneous nivolumab can reduce burdens on the health care system and patients with pretreated advanced or metastatic clear cell renal cell carcinoma compared with its IV formulation, according to data from a phase 3 CheckMate 67T trial.

Healio has compiled a list of the most-read nephrology cover stories in 2023.

The FDA approved belzutifan for treatment of adults with advanced renal cell carcinoma.

Researchers found no association between Agent Orange exposure and hepatocellular carcinoma among Vietnam veterans, according to study results published in JAMA Network Open.

NASHVILLE, Tenn. — Fewer than one in 20 patients with kidney cancer who meet guidelines for genetic evaluation received genetic counseling, according to findings presented at International Kidney Cancer Symposium: North America.

NASHVILLE, Tenn. — Alexander Kutikov, MD, FACS, received Kidney Cancer Association’s Andrew C. Novick Award.